Summary: The antiepileptic drugs phenobarbital and phenytoin were determined in serum by enzyme immunoassay (Emit, Syva Corp.) and gas-liquid chromatography. The Emit assays were mechanized by the use of an Eppendorf analyzer 5010. The precision of the Emit system was sufficient (coefficient of variation within series 6-13% and from day to day 8-15% with various calibrators and control sera). Moreover the Emit method is rapid, specific and easy to perform. The procedure requires only 10 of serum per determination. A disadvantage however is the high cost of the reagents. A comparison of the results obtained by Emit and gas-liquid chromatography in a series of about 50 patients showed a good correlation between both methods (correlation coefficient r = 0.968 for phenobarbital and 0.978 for phenytoin).
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Material and Methods
Origin of specimens Serum samples (n = 90) containing phenytoin and phenobarbital, a metabolite of primidone, were obtained from epileptic patients of our hospital. Control sera were purchased from Syva Corporation (AED, antiepileptic drug control) and from Laboratories Biotrol in Paris (Biotrol-therapeutique).
Materials
The reagents for the enzyme immunoassay (Emit) were purchased from Syva Corp. (Palo Alto, California 94309). Substances tested for cross-reactivity were a generous gift of the manufacturers of the drugs mentioned by trade names.
Gas-Liquid Chromatography
The determination of phenobarbital and phenytoin by gasliquid chromatography was carried out according to a modified version of the procedure viFiereck & Tietz (8) without methylation (K lpmann, W. R. in preparation). 2 ml of saturated (NH 4 ) 2 SO 4 solution is added to 1 ml of the serum sample. The mixture is extracted 3 times with 5 ml chloroform. The organic phase is dried over Na 2 SO4 and evaporated. The residue is washed down from the tube sides with 200 μΐ ethyl acetate/acetic acid (volumes, 100 ml + 1 ml) and evaporated again. Then the dried residue is dissolved in 100 μΐ of ethyl acetate/acetic acid (volumes, 100 ml + 1 ml); 2 μΐ of this solution are injected into the gas Chromatograph. A Varian model 1800 gas Chromatograph (Varian, Darmstadt, FRG) equipped with a dual hydrogen flame detector is used. Glass columns are silanised (180 cm X 2.2 mm, i. d.). They are packed with 3% SP 2250 DA on 100-120 mesh Chromosorb WHP (Supelco, Bellefonte, Pennsylvania). Carrier gas flow rate is 40 ml/min, hydrogen 30 ml/min, and air 300 ml/min. The column temperature is maintained at 230 °C, the inlet and the detector at 260 °C. The change of absorbance during the 150 seconds reading time is shown for various pheriobarbital concentrations in figure 3 . Similar results were obtained by the Emit phenytoin assay. There is a non-linearity between 30 and 80 seconds, then the curve becomes almost linear. The 150 seconds reading time ensures an adequate absorption change, for sufficient sensitivity. The absorbance change produced by the blank is considerable. The difference between this blank value and the absorbance changes caused by the various calibrators is comparatively low. This ratio appears to be unfavorable with respect to the precision. The same disadvantages were observed with the original (9) and a modified procedure (7). 
Precision
The precision of the Emit system for the quantitative determination of phenobarbital and phenytoin in serum at various concentrations of calibrators and commercial control sera is shown in table 2, With most of the calibrators and control sera tested the coefficient of variation withiri series ranged from 6-13% and from day to day from 8-15%. The precision within series of gas-liquid chrpmatography was determined by the repeated analysis (n = 10) of a spiked human serum containing phenobarbital (2 .Q mg/1) and phenytoin (20 mg/1). The average phenobarbital concentration found was 20.0 mg/1 with a coefficient of variation of 3,8%. The average phenytoin' concentration was 19.2 mg/1 with a coefficient of variation of 4.7 %. From day to day variation was determined by analyzing Furthermore phenobarbital and phenytoin levels were determined by gas-liquid chromatography and Emit in sera from patients on a medication of primidone ( = 57) and phenytoin (n = 43).
For the measurement of phenobarbital, the leastsquares regression analysis of 57 specimens ( fig. 4) showed the slope of the line to be 0.95. The value of the intercept was 1.39 mg/1. Random error was estimated at 11.5 mg/1 from the standard error (10) . The correlation between the results was high (r = 0.968). For a gas-liquid Chromatographie value of 30 mg/1, the Emit procedure would give an average value of 29.9 mg/1 (standard error S y = 11.5 mg/1). 
Specificity
The specificity of the Emit assays was tested by the determination of the cross-reactivity with structurally related compounds and other antiepileptic drugs. The results obtained with spiked human serum samples are shown in table 5. For each drug the concentration was determined at which it exerts an absorbance equivalent to 5 rng/1 phenobarbital or phenytoin in the corresponding Emit assay. The Emit phenytoin assay seemed to be very specific. In addition to the phenytoin metabolite, SHtp-hydroxypheny^S-phenylhydantoin, only mephenytoin slightly cross reacted in this assay. It should be noted that phenytoin-3-norvälme is apparently completely metabolized in vivo so that serum levels cannot be determined. With serum samples from patients (n = 20) receiving various drugs other than phenytoin no positive results were observed.
The Emit phenpbarbital assay was less specific. Methylphenobarbital, cyclobarbital, cyclppal, and amobarbital showed a cross-reaction. Serum ßamples from patients Clinical experience The measurement of phenytoin and phenobarbital appears to be of great clinical value. In many cases irregular drug intake and inadequate dosage could be objectified and the diagnosis of an intoxication confirmed. To illustrate the clinical relevance of the determination of antiepileptic drug levels an example from our pediatric clinic is given in figure 6 . A twelve year old girl treated with phenytoin and primidone, was sent to our pediatric clinic because of toxic symptoms such as nystagmus and ataxia, which increased during the following days. The clinical signs pointed to an intoxication by phenytoin.
This diagnosis was confirmed by the determination of the serum levels of phenobarbital and phenytoin. The serum levels of phenytoin were far above the therapeutic range, whereas the phenobarbital concentrations only slightly exceeded the recommended values. After the phenytoin medication was discontinued the phenytoin level decreased and the toxic symptoms disappeared. 
